Publication | Closed Access

Mitoxantrone-induced DNA damage in leukemia cells is enhanced by treatment with high-dose arabinosylcytosine

Hematological MalignancyMedicineMalignant Blood DisorderHigh-dose ArabinosylcytosineLeukemia CellsAnti-cancer AgentPharmacologyCell BiologyMitoxantrone-induced Dna DamageMyeloid Neoplasia